216 related articles for article (PubMed ID: 33640616)
1. Neuroprotective gain of Apelin/APJ system.
Zhou JX; Shuai NN; Wang B; Jin X; Kuang X; Tian SW
Neuropeptides; 2021 Jun; 87():102131. PubMed ID: 33640616
[TBL] [Abstract][Full Text] [Related]
2. Apelin/APJ system: an emerging therapeutic target for neurological diseases.
Li A; Zhao Q; Chen L; Li Z
Mol Biol Rep; 2023 Feb; 50(2):1639-1653. PubMed ID: 36378421
[TBL] [Abstract][Full Text] [Related]
3. Novel pathogenesis: regulation of apoptosis by Apelin/APJ system.
Liu J; Liu M; Chen L
Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):471-478. PubMed ID: 28407045
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Roles of Apelin-13 in Neurological Diseases.
Zhang Y; Jiang W; Sun W; Guo W; Xia B; Shen X; Fu M; Wan T; Yuan M
Neurochem Res; 2023 Jun; 48(6):1648-1662. PubMed ID: 36745269
[TBL] [Abstract][Full Text] [Related]
5. Apelin-13/APJ system attenuates early brain injury via suppression of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation and oxidative stress in a AMPK-dependent manner after subarachnoid hemorrhage in rats.
Xu W; Li T; Gao L; Zheng J; Yan J; Zhang J; Shao A
J Neuroinflammation; 2019 Dec; 16(1):247. PubMed ID: 31791369
[TBL] [Abstract][Full Text] [Related]
6. Impact of the apelin/APJ axis in the pathogenesis of Parkinson's disease with therapeutic potential.
Angelopoulou E; Paudel YN; Bougea A; Piperi C
J Neurosci Res; 2021 Sep; 99(9):2117-2133. PubMed ID: 34115895
[TBL] [Abstract][Full Text] [Related]
7. Apelin/APJ system: A novel promising target for anti-aging intervention.
Zhou Q; Chen L; Tang M; Guo Y; Li L
Clin Chim Acta; 2018 Dec; 487():233-240. PubMed ID: 30296443
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity.
Cabiati M; Gaggini M; De Simone P; Del Ry S
Clin Exp Med; 2021 May; 21(2):269-275. PubMed ID: 33201338
[TBL] [Abstract][Full Text] [Related]
9. Apelin/APJ system in inflammation.
Wang X; Zhang L; Li P; Zheng Y; Yang Y; Ji S
Int Immunopharmacol; 2022 Aug; 109():108822. PubMed ID: 35605524
[TBL] [Abstract][Full Text] [Related]
10. Apelin/APJ system: A bifunctional target for cardiac hypertrophy.
Lu L; Wu D; Li L; Chen L
Int J Cardiol; 2017 Mar; 230():164-170. PubMed ID: 27979574
[TBL] [Abstract][Full Text] [Related]
11. Apelin/APJ system: A potential therapeutic target for endothelial dysfunction-related diseases.
Cheng J; Luo X; Huang Z; Chen L
J Cell Physiol; 2019 Aug; 234(8):12149-12160. PubMed ID: 30585633
[TBL] [Abstract][Full Text] [Related]
12. Apelin receptor homodimer inhibits apoptosis in vascular dementia.
Wang D; Wang Y; Shan M; Chen J; Wang H; Sun B; Jin C; Li X; Yin Y; Song C; Xiao C; Li J; Wang T; Cai X
Exp Cell Res; 2021 Oct; 407(1):112739. PubMed ID: 34343559
[TBL] [Abstract][Full Text] [Related]
13. Apelin/APJ system: A novel promising target for neurodegenerative diseases.
Luo H; Han L; Xu J
J Cell Physiol; 2020 Feb; 235(2):638-657. PubMed ID: 31254280
[TBL] [Abstract][Full Text] [Related]
14. Apelin-36, a potent peptide, protects against ischemic brain injury by activating the PI3K/Akt pathway.
Gu Q; Zhai L; Feng X; Chen J; Miao Z; Ren L; Qian X; Yu J; Li Y; Xu X; Liu CF
Neurochem Int; 2013 Nov; 63(6):535-40. PubMed ID: 24083989
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effect of electroacupuncture in cardiopulmonary bypass through apelin/APJ signaling.
Wang K; Ju Z; Chen C; Fan S; Pei L; Feng C; Wang F; Cui H; Zhou J
Life Sci; 2020 Feb; 242():117208. PubMed ID: 31870773
[TBL] [Abstract][Full Text] [Related]
16. Apelin/APJ system: A novel therapeutic target for locomotor system diseases.
Luo J; Liu W; Feng F; Chen L
Eur J Pharmacol; 2021 Sep; 906():174286. PubMed ID: 34174264
[TBL] [Abstract][Full Text] [Related]
17. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
Huang Z; He L; Chen Z; Chen L
J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
[TBL] [Abstract][Full Text] [Related]
18. Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury.
O'Donnell LA; Agrawal A; Sabnekar P; Dichter MA; Lynch DR; Kolson DL
J Neurochem; 2007 Sep; 102(6):1905-1917. PubMed ID: 17767704
[TBL] [Abstract][Full Text] [Related]
19. Apelin/APJ relieve diabetic cardiomyopathy by reducing microvascular dysfunction.
Li B; Yin J; Chang J; Zhang J; Wang Y; Huang H; Wang W; Zeng X
J Endocrinol; 2021 Apr; 249(1):1-18. PubMed ID: 33504680
[TBL] [Abstract][Full Text] [Related]
20. The apelin/APJ system as a therapeutic target in metabolic diseases.
Castan-Laurell I; Masri B; Valet P
Expert Opin Ther Targets; 2019 Mar; 23(3):215-225. PubMed ID: 30570369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
